15707966 Script Essentials, LLC Suzy Cohen
The present disclosure is a compound, a method of making the compound and method of using such compound preferably in the form of a dietary supplement that, when administered, is capable of treating heart disease and heart-related disorders, among other symptoms. The unique combination of the composition is preferably administered orally. The composition is preferably comprised of about 1,000 to 5,000 IU of vitamin D, preferably cholecalciferol, about 250 to 1,250 mg of fish oil concentrate, about 200 to 1,200 mg of omega-3 fatty acids, about 200 to 700 mg of DHA, about 20 to 125 mg of EPA, and about 10 to 150 mg of other fatty acids. The composition can further comprise a palliative agent, and can be provided in the form of a softgel, powder, liquid or tablet.